- Research article
- Open Access
Transcriptome analysis of embryonic mammary cells reveals insights into mammary lineage establishment
Breast Cancer Research volume 13, Article number: R79 (2011)
The mammary primordium forms during embryogenesis as a result of inductive interactions between its constitutive tissues, the mesenchyme and epithelium, and represents the earliest evidence of commitment to the mammary lineage. Previous studies of embryonic mouse mammary epithelium indicated that, by mid-gestation, these cells are determined to a mammary cell fate and that a stem cell population has been delimited. Mammary mesenchyme can induce mammary development from simple epithelium even across species and classes, and can partially restore features of differentiated tissue to mouse mammary tumours in co-culture experiments. Despite these exciting properties, the molecular identity of embryonic mammary cells remains to be fully characterised.
Here, we define the transcriptome of the mammary primordium and the two distinct cellular compartments that comprise it, the mammary primordial bud epithelium and mammary mesenchyme. Pathway and network analysis was performed and comparisons of embryonic mammary gene expression profiles to those of both postnatal mouse and human mammary epithelial cell sub-populations and stroma were made.
Several of the genes we have detected in our embryonic mammary cell signatures were previously shown to regulate mammary cell fate and development, but we also identified a large number of novel candidates. Additionally, we determined genes that were expressed by both embryonic and postnatal mammary cells, which represent candidate regulators of mammary cell fate, differentiation and progenitor cell function that could signal from mammary lineage inception during embryogenesis through postnatal development. Comparison of embryonic mammary cell signatures with those of human breast cells identified potential regulators of mammary progenitor cell functions conserved across species.
These results provide new insights into genetic regulatory mechanisms of mammary development, particularly identification of novel potential regulators of mammary fate and mesenchymal-epithelial cross-talk. Since cancers may represent diseases of mesenchymal-epithelial communications, we anticipate these results will provide foundations for further studies into the fundamental links between developmental, stem cell and breast cancer biology.
The mammary lineage is first established during organogenesis of the mammary primordium that forms during embryogenesis. Mammary primordia, comprised of mammary epithelial and associated mesenchymal tissues, develop as a result of inductive crosstalk between the surface epithelium and underlying mesenchyme . During mouse embryogenesis, a multilayered epithelial mammary placode is evident at embryonic day (E) 11.0, which reaches the bud stage by E12.0. When E13.0 mammary primordial epithelium and salivary mesenchymal tissue are co-cultured, they produce a ductal tree that has morphological features of salivary ducts, but is capable of secreting milk . These results suggest that by E13.0, mammary epithelium has been stably determined as mammary. Mammary mesenchyme can induce mammary differentiation in non-mammary epithelium, even from epithelium of other mammalian species and across classes, suggesting that the inductive signals provided by the mammary mesenchyme and the responding elements in the uninduced epithelium are highly conserved during mammalian evolution . Together, the embryonic mammary epithelial and mesenchymal tissues act together as a signalling centre and communicate back and forth to each other to mediate all stages of embryonic mammary morphogenesis.
Another key aspect of organogenesis is the formation of tissue-specific stem cells. To identify at what developmental stage these stem cells first form, mammary primordia from different embryonic stages have been implanted into fat pads cleared of mammary epithelium to evaluate their repopulation capacity, which provides a measure of stem cell activity within a population. In these experiments, mammary primordia from E12.5 onwards formed extensive arborised ducts and have been used to evaluate postnatal mammary phenotypes in mice with genetic mutations which exhibit embryonic lethal phenotypes . Moreover, mammary epithelium, isolated from E13.0 mammary primordia, independent of mammary mesenchyme, can give rise to all mammary epithelial cell types in this assay, and can even induce the formation of milk-secreting mammary alveoli in fat pads of pregnant females . These observations suggest that tissue-specific stem cells reside within the primordial mammary epithelium by mid-gestation and that these cells have the ability to respond to the postnatal microenvironment in an appropriate fashion. However, the molecular identity of the epithelial cells in the mammary primordia is still ill defined, and the degree of similarity to postnatal mammary epithelial cells remains largely unknown.
To investigate new candidates for inductive tissue interactions in the mammary primordia, we have now profiled the gene expression signatures of purified mammary primordia and their epithelial and mesenchymal tissues in mid-gestation mouse embryos to identify genes specific for both cellular subpopulations. We have further compared the embryonic mammary expression patterns to their postnatal descendants using existing array data for the basal, luminal estrogen receptor positive and luminal estrogen receptor negative subpopulations of  to identify candidate markers for mammary progenitor regulators. Comparison of the mammary mesenchymal and postnatal stromal signatures provides new insights into likely effectors of mammary cell fate, lineage promotion and maintenance. Together, our results provide a global picture of signalling networks that may regulate key aspects of mammary organogenesis, including inductive signalling events, the initial establishment of the mammary lineage and mammary progenitor behaviour.
Materials and methods
All animal work was carried out under UK Home Office project and personal licenses following local ethical approval and in accordance with local and national guidelines. Embryonic day 12.5 (E12.5) mammary primordia number four were manually micro-dissected from FVB/N embryos in ice-cold D-PBS so that a thick layer of mesenchyme was left associated with the mammary epithelial bud. Based on histological and confocal data, the layer of mesenchymal cells consisted of a depth of approximately 8 to 16 cells and should include mostly estrogen receptor-alpha (ERα) expressing cells. Similar micro-dissected samples were digested for two minutes with pancreatin and trypsin, rinsed extensively in D-PBS to remove the enzymes. One hour later, primordia were separated with needles into two cell compartments, the mammary bud epithelium and the mammary bud-associated mesenchyme as described by . All samples were collected in RLT buffer plus β-mercaptoethanol and frozen on dry ice. Samples isolated from pools of 15 to 22 mammary primordia were used for each biological replicate.
RNA samples were isolated using Qiagen RNeasy Micro Plus Kit (Qiagen, Hilden, Germany). Quality control, labelling and microarray hybridisation were performed at the Paterson Institute for Cancer Research, Molecular Biology core facility (Manchester, UK).
Three biological replicates for each of the populations (micro-dissected mammary primordia, purified mammary primordial epithelium, purified mammary primordial mesenchyme) were amplified. Approximately 100 to 150 ng RNA was amplified with NuGEN amplification (NuGEN Technologies Inc., San Carlos, California, USA) and hybridised to MOE 430 2.0 Affymetrix arrays (Affymetrix Ltd, High Wycombe, UK).
Primordial marker expression analyses
Immunohistochemistry (IHC) and whole-mount immunofluorescence (WM-IF) of E12.5 mammary primordia were performed as previously described [7, 8]. Antibodies used in WM-IF or IHC are listed in Additional file 1. Whole mount in situ hybridisation of E12.5 mouse embryos and probes (sense and anti-sense) corresponding to nucleotides of 707-1050 NM_009242 for Sparc, 416-1139 of NM_023655 for Trim29 and 506-1206 of NM_032000 for Trps1 were generated as previously described .
Quantitative real-time RT-PCR
To compare gene expression between the epithelium and mesenchyme at E12.5, total RNA was extracted from the purified mammary primordial compartments and three replicas were run with Taqman Array Assays-on-Demand probes on freshly isolated RNA (Applied Biosystems, Warrington, UK). Results were analysed with the Δ-ΔCt method normalised to Actb.
Expression data were normalised and summarised by robust multi-array analysis (RMA) using the affy package in R. Probe sets were used for a multiclass Significance Analysis of Microarray (SAM) to determine if their mean expression was different across the three primordial populations. Two-class unpaired SAM was applied to determine genes enriched in one population when compared to another using a local false discovery rate (FDR) of 5%. Probe sets were used for a multiclass Significance Analysis of Microarray to determine if their mean expression was different across the three mammary epithelial cell (MEC) subpopulations described in  and the three primordial populations. A total of 4,000 probes identified in the multiclass SAM comparing the embryonic mammary populations with a FDR < 5% were clustered in R. Probes were centred by the median and clustered on the basis of their correlation distance using a Ward algorithm. In the embryonic-postnatal mammary analysis, the top 2,498 probes with a median absolute deviation (MAD) greater than two were clustered in R. Probes were centred by the median. Results were visualised in Java Treeview. Probes were considered population-enriched when they had a mean relative abundance of 1.5 or more. The microarray data have been submitted to the ArrayExpress repository with accession number [E-TABM-1099].
Network interaction maps were provided by uploading gene lists into a web-based in-house bioinformatics package and database, ROCK, developed based on the pSTIING server . The core interaction maps were constructed using differentially expressed genes using only direct interactions characteristic of each population and produced one large interaction module for each tissue. Genes that did not directly connect are excluded. Interaction maps are displayed using ROCKscape with nodes representing proteins and edges representing interaction or transcriptional regulatory relationships between components. Sub-modules are identified based on observation of multiple interconnecting nodes within node groups that appear on the interaction map as separable node clusters. The interaction map generated by connecting the epithelial and mesenchymal populations was manually curated to ensure that interpolated connecting genes were appropriate (so that, for instance, transcription factors did not appear as nodes connecting genes across the epithelial and mesenchymal populations). Functional annotation for genes was determined using the Gene Ontology tool at the Mouse Genome Informatics website  and with the DAVID Bioinformatics Resource . To determine the degree of similarity of gene expression profiles of mammary primordial cell populations and postnatal mammary and breast cells, genes considered characteristic of mouse postnatal mammary cells from  or the conserved mouse-human progenitor cells from  were compared to those of the embryonic mammary cells. The similarities are based on absolute present calls.
Isolation of mammary primordial cell populations
Precise synchronised signals are thought to mediate the initial stages of mammary primordial development, since early stages of mammary morphogenesis progress in a highly stereotypical manner . A limited amount of cell proliferation is observed within the mammary primordial epithelium during the early stages (E11.0 to E13.5) of mammary organogenesis. Localised cell movements are, therefore, thought to increase epithelial cell number during these stages of mammary development. To identify candidate signalling pathways and networks that are active during mammary organogenesis at a stage in which mammary inductive signalling and stem cell delimitation are occurring, we have generated data to define the mammary primordial transcriptome from stage E12.5 mouse embryos. This entailed micro-dissection of the fourth pair of mammary primordia from two or three litters of FVB/N embryos for each replicate (Figure 1A-C). In a second set of experiments, we separated the micro-dissected mammary primordia into their epithelial and mesenchymal cell populations (Figure 1D, E). In all experiments, the dissected mammary primordia included several layers of surrounding cells to gather the ERα-positive mesenchymal cells, which are arranged in layers of concentric circles around the mammary bud epithelium (Figure 1A, B).
Gene expression profiling of mammary primordia and their epithelial and mammary mesenchymal cell populations
RNA was isolated from micro-dissected mammary primordia, and mammary primordial epithelium and mesenchyme from matched tissue pools. RNA was labelled by Nugen amplification and hybridised to MOE 430 2.0 Affymetrix arrays. Significance Analysis of Microarray (SAM) was applied to identify genes showing distinct expression patterns across the three different cell populations at an FDR < 0.05. Using these parameters, 4,000 probes were found to be differentially expressed among the enzymatically separated tissues and the micro-dissected primordia which were included to assess whether probes expressed by the separated tissues were present in the intact primordial samples (Figure 1F and Additional file 2). A total of 749 probe genes were upregulated 1.5-fold or greater at an FDR < 0.05 in the primordial epithelium compared to its associated mesenchyme when the mean relative abundance was 1.5 or greater (Additional file 2). Known key regulators of normal mammary primordial development, including Edar, Fgfr2, Gata3, Msx1, Msx2, Nrg3, Pthlh, and multiple Wnt signalling components were expressed specifically within the embryonic mammary epithelium when compared to the mesenchyme (Additional file 2) [15–23]. Amongst these, 25 genes were already known to be expressed in mid-gestation mammary primordia (Additional file 2). The technique used to separate the two tissues had relatively little effect on gene expression (Additional file 2). Using quantitative qRT-PCR, whole mount in situ hybridisation (WM-ISH), whole mount immunofluorescence (WM-IF), immunofluorescence (IF) and immunohistochemistry (IHC) we confirmed epithelial-enriched expression for 18 genes (Figure 2A, B). In addition, we detected expression of many other growth factors, receptors, and transcription factors not previously ascribed to the embryonic mammary epithelium (Additional file 3). RNA and protein expression studies have validated several population-enriched gene expression profiles detected by the array analysis and indicate the dataset represents a reliable global genetic profile of the primordial cell populations.
Transcriptional network of mammary primordial development
A core network module (Additional files 3 and 4) was generated using ROCKscape, a modification of Cytoscape [24, 25] by using the human orthologues of genes expressed by the E12.5 mammary primordial epithelium, as described in Additional file 2; only genes encoding proteins that have previously been shown to directly interact with each other were used to make this network. HEAT SHOCK PROTEIN 1 (HSPB1) is the mostly highly connected node and links to a keratin sub-module that is poised to maintain the structural integrity of the primordial epithelium. Other highly connected nodes include β-CATENIN (CTNNB1), an adherents junctions component and major effectors of Wnt signalling, PLAKOGLOBIN (JUP), PI3-KINASE (PIK3R1) and the actin-binding mediators, DUCHENNE MUSCULAR DYSTROPHY (DMD) and ACTIN-BINDING LIM PROTEIN 1 (ABLIM1). Less connected nodes include a kinase activin receptor sub-module (Figure 2C), a collagen-PDGF sub-module, an integrin/cell adhesion sub-module and a receptor-signalling sub-module. These sub-modules consist of genetic elements, many with established roles in the regulation of epithelial signalling and morphogenesis, including genes involved in focal adhesion, cell contractility, cell-matrix adhesion, and extracellular matrix (ECM)-receptor interactions. The sub-module in Figure 2C contains one node, DISCOIDIN RECEPTOR 1 (DDR1) which is known to regulate both branching morphogenesis and terminal differentiation in the postnatal mammary gland and is poised to interact with two activin receptors, represented by nodes ACVR1B and ACVR2B . Inhibbin-B, a ligand for both activin receptors, is required during puberty and pregnancy for normal mammary ductal elongation and alveolar development . This sub-module is, therefore, likely to represent biologically relevant interactions, since branching morphogenesis is a modified version of budding morphogenesis (that is, when a cluster of progenitor cells located within distinct boundaries moves, rearranges and proliferates to form an organ) and also identifies other kinases as novel potential bud morphogenetic regulators. Some signals within the epithelial cells should represent responses that have been induced by the mesenchyme (that is, activated receptors and their downstream effectors) as well as signals that will be sent to the mesenchyme (secreted factors).
A limitation of networks based on transcriptomic studies is that mRNA and protein levels do not always correlate. To address this to a small extent and further refine our understanding of the signalling characteristics of the primordial cells, we focused on validating expression patterns of markers within our network interaction maps using immunohistochemistry or immunofluorescence, rather than only qRT-PCR and ISH. Immunohistochemical analysis can be used to determine whether key nodes (based on number of interactions with other nodes and/or previous association with lineage) are present at the protein level and, therefore, are potentially signalling. This approach also permits detection of the precise location and fraction of cells within the mammary primordium that express putative effectors. One notable epithelial core network member, Trim29, appears to be restricted to the basal epithelial layer of the mammary epithelium at stages prior to the polarised postnatal localisation of the classic basal Keratins, Krt5 and Krt14, which are expressed by many basal and suprabasal mammary epithelial cells at E12.5. Trim29, therefore, represents one of the first mammary primordial markers expressed in a basally-enriched pattern, aside from the basal lamina components (Figure 2A). Trim29 can interact with Krt17, a keratin associated with stratification of epithelial appendages , which is expressed by basal cells of the postnatal mammary epithelia . The location of Trim29 within the sub-module highlights a likely role in regulating processes related to both cell structure and lineage. In the postnatal mammary epithelium, keratins become predominantly segregated by expression within MECs of either the myoepithelial (Krt5, Krt14, Krt17) or luminal lineages (Krt8, Krt18).
Population-enriched expression was observed for 642 probes at FDR < 0.05 in the mammary mesenchyme associated with the mammary primordium when compared to the epithelium when the mean relative abundance was 1.5 or greater (Additional file 2). We detected the previously reported mesenchymal-enriched expression of Fgf7, Tbx15, and Tnc [17, 29–31]. We confirmed mesenchymal-enriched expression for 13 genes using qRT-PCR, WMISH, and WM-IF (Figure 3A, B). Major transcriptomic pathway components expressed specifically within the mammary mesenchyme are summarised in Additional file 5, including many growth factors, receptors, and transcription factors. A core network module (Additional file 5 and 6) was generated using ROCKscape based on the human orthologues of directly interacting genes characteristic of the mesenchyme associated with the E12.5 mammary primordial epithelium listed in Additional file 2. A highly interconnected sub-module comprised of G protein coupled receptor signalling and cytokine signalling is evident and contains key mediators of metastasis and invasive growth, such as CXCR4 and its ligand CXCL12/SDF  (Figure 3C). This sub-module connects to another highly interconnected sub-module comprised of cytoskeleton and cell movement components via the node, GELSOLIN, (GSN). The actins binding protein, (Gsn), is required in postnatal stroma for proper mammary ductal elongation into the fat pad during puberty and this phase of invasive growth is very delayed in its absence . In addition to suggesting a possible role for Gsn in the regulation of embryonic mammary epithelial morphogenesis, the network analysis identifies connections to plausible interaction partners since both CXCR4 and CXCL12/SDF have well-established roles in invasive cell behaviour. Many mesenchymal nodes represent genes involved in angiogenesis, chemotaxis, and neural pathfinding (Additional file 6). One node, NEUROPILIN2 (NRP2), is highly expressed in the mammary mesenchyme array data and was validated by qRT-PCR (Figure 3B); Nrp2 appears to stain nerves (Figure 3A) whilst other markers appear to stain forming blood vessels in the mammary mesenchymal region that was dissected out and profiled (Figure 1A). This indicates that despite its indistinct and homogenous cellular appearance, mammary mesenchymal components (neural, vasculature, fat cells) indicated by signature, pathway, and network analyses are likely to reflect ongoing developmental processes associated with specific cell types. Some mesenchymal markers are expressed in sub-domains that could represent or promote the formation of distinct sub-compartments within the mammary mesenchyme.
Potential mammary-inducing factors, lineage promoters and key signalling processes identified
By E13.0, embryonic mammary mesenchyme from mice can induce surface epithelium to adopt a mammary cell fate , so E12.5 mammary mesenchyme should be enriched for mammary inducing factors. Postnatal stromal cells are not thought to harbour mammary inductive potential. Factors with the potential to transmit mammary-inductive signals were identified by analysing gene expression profiles enriched within the mammary mesenchyme compared to stromal signatures described in . Several secreted factors including Dlk1 and Gas1, fulfil this criterion and as such are potential mammary-inducing factors (Additional file 7).
To identify potential promoters of mammary differentiation from the inception of the mammary lineage onwards, we compared genes expressed by the mammary mesenchyme with genes expressed by the mammary stroma profiled by  (Additional file 8). Genes expressed by both tissues could promote mammary differentiation throughout mammary development and act as lineage reinforcers to maintain mammary cell identity. Several secreted factors are classified as potential mammary lineage reinforces including, Ccl11, Dab2, Dcn, Igf1, Fgf7, Figf, Gpc3, Sparcl1, Slit2, Thbs2, Tmeff2, and Wisp1 (Additional file 8). These molecules could signal directly to the primitive and mature MECs to promote mammary cell fate. In addition, several transcription factors also fall into this category, including Ebf1, Ebf3, Gata6, Klf4, Maf, Nr2f1, Osr2, Prrx1, Prrx2, Tcf4, Tbx15, and Tbx18, which may contribute to promotion of the mammary cell fate via transcriptional regulation of other particular key factors that can transmit signals to the adjacent MECs. Comparison of genes expressed by the mammary mesenchymal cells with genes expressed by human breast stromal cells identifies some common genes (Additional file 8). This may indicate a conserved function of some stromal signals across species with respect to mammary lineage promotion and maintenance.
The mammary primordial epithelial and mesenchymal core network modules were interconnected to identify prospective mediators of mesenchymal-epithelial interactions (Additional file 9). Some of the putative mammary inductive signals expressed by cells in the mammary mesenchyme are found in the core interconnected network module and plausible signalling partners or signalling components have been identified in the mammary bud epithelium (Figure 4A, B). For example, Decorin (Dcn) is expressed by mesenchymal cells immediately adjacent to the mammary bud epithelium (Figure 4C). Decorin, a proteoglycan, is secreted and thus poised to interact with epithelial cells expressing Col4a5 and Col4a6 (CollagenIV) at the epidermal-mesenchymal boundary (Figure 4D). Studies of Dcn-null mice have identified a role for Dcn in the regulation of collagen fibril assembly which is thought to lead to the formation of a barrier to cell penetration and macromolecule infiltration . Decorin has also been implicated in the modulation of both postnatal mammary stromal cell phenotypes and MEC behaviour in tumours , suggesting that Decorin may play a regulatory role in mediating mammary tissue interactions from early developmental stages onward. Established regulators of mesenchymal to epithelial signalling such as Inhbb (activin/inhibin beta b) are represented in this network (Additional files 9 and 10). Several secreted factors are found that could interconnect nodes to mediate signal transduction across the two tissue compartments via paracrine signalling (Figure 4A). Many interactions that are poised to connect the epithelial and mesenchymal cells (by virtue of their compartment-enriched expression and known ability to interact) could modulate extracellular matrix organisation and cell adhesion and would, therefore, profoundly alter the microenvironment of progenitor cells in the basal layer of the epithelium.
Comparison of gene expression profiles of mammary primordial cell populations reveals similarities and differences with their direct descendants
The mammary primordial populations profiled were isolated from the fourth primordial (of the five pairs) from the FVB strain so a direct comparison to the postnatal mammary epithelial cell sub-populations (basal, luminal ER-, luminal ER+) was possible which were also isolated from the FVB strain and the fourth (inguinal) mammary gland (Figure 5A and Additional file 11) . As such, the postnatal cells should represent the descendants of the primordial cells. Three major classes of genes can be identified: those expressed within the postnatal cell populations and not expressed by the primordial cells (postnatal mammary), those expressed within the primordial cells and not expressed by the postnatal cells (embryonic mammary), and those that are expressed by both the prenatal and postnatal mammary cell populations (shared embryonic/postnatal mammary) (Figure 5A). Gene expression patterns shared between primordial and postnatal mammary sub-populations may represent effectors capable of impacting mammary cell behaviour regardless of their level of differentiation (Figure 5B and Additional file 12). The mammary primordial epithelial cells are an immature mammary epithelial cell population and lack markers of differentiated cell types, such as ERα, which is expressed by cells in the luminal ER+ population or SMA which is expressed by myoepithelial cells which comprise the bulk of the basal population (Figures 1B and 5C) .
We also compared our embryonic mammary gene signatures to the terminal end bud (TEB) and mature ductal signatures derived from the dataset described by Kouros-Mehr and Werb . This dataset represents profiles of micro-dissected tissues containing both epithelial cells and immediately adjacent stroma at puberty, a key developmental stage during which the TEB exhibits invasive directional growth through the fat pad, resulting in ductal elongation and branching. We found a small number of genes expressed by embryonic mammary cells and ductal or TEB cells, including Anxa8, Dlx3, Kitl, Klf4, Pthlh, Sema3c. Sox11, Sox18, Thbs1, Trps1, Wnt6, and Wnt7b. Genes expressed at both of these critical developmental stages may represent master mammary morphogenetic or lineage regulators (Additional files 12 and 13). Of these, some are also expressed by human stromal cells including Col3a1, Fbn1, Igf1, Kera, On, Ptgis, Thbs2, Timp3, Tmeff2, and Vcam1.
By E13.0, the mammary primordial epithelium is determined to mammary cell fate, so at this slightly earlier developmental stage, E12.5, profiled here, the primitive mammary epithelium is either stably or nearly determined to the mammary lineage and, therefore, genes regulating mammary progenitor cell function should be expressed. Since other organs express the same transcription factors in stem/progenitor cells at both embryonic and postnatal stages, we looked for shared transcriptional programs across the embryonic and postnatal mammary cells to ascertain potential tissue-specific transcription factors and other signalling regulators, which we predict should be involved in mammary cell fate and progenitor function (Additional file 13). Examples of transcription factors that are expressed in both primordial and postnatal MEC sub-populations and have critical roles in regulating progenitor biology include Elf5 and Sox6 [5, 39]. Several mammary stem cell-enriched and progenitor-enriched markers are expressed by the mammary primordial cells (Figures 2A, 5C and Additional file 13).
Comparison of the primordial populations to the postnatal mammary cell populations reveals subsets of genes that are expressed within both the mammary primordial epithelium and associated mesenchyme (Figure 5A and Additional file 13). Some of these include classic EMT genes, including Twist1 and Twist2, which are associated with loss of epithelial characteristics when expressed by adherent epithelial cells and acquisition of mesenchymal features (Additional file 13). Confocal analysis of the mammary primordium shows a very heterogeneous population of cell types, some with a nucleus and shape resembling fibroblasts (Figure 1A). We have found that a small population of the primitive mammary epithelial cells express an epithelial-mesenchymal transition (EMT)-associated marker Sox9 and Vimentin, a mesenchymal marker expressed by some bona fide epithelial cells, as well as those undergoing EMT (Figure 5C). Myoepithelial cells also express EMT-associated genes so their expression by the various mammary cell populations is likely to reflect their shared developmental origin from the basal epithelium, including an underlying transcriptional program that acts to repress epithelial differentiation and promote cell motility. Primordial epithelial cells with EMT features may have great pertinence to the initial generation of mammary stem cells since recent data suggest that induction of EMT stimulates cultured breast cells to adopt characteristics of stem cells .
Comparison of gene expression profiles of mammary primordial cell populations reveals transcriptomic similarities to human breast progenitor profiles
We also compared genes expressed in both the mammary primordium and the subpopulations of MECs that are conserved across mouse and human, which have recently been described . We observed some overlapping gene expression with the primordial cell populations and the "mammary stem cell (MaSC)" populations, luminal progenitor and mature luminal populations (Additional file 13). Genes with established or anticipated roles in mammary progenitor biology, including Itga6 and Msx1, are expressed by the mammary primordial cells, and by the conserved mouse-human mammary progenitor populations (Additional file 14). Many genes expressed by both the primordial and conserved mouse/human mammary stem cell-enriched populations are also found within the core network modules which suggests that the primordial core networks reflect elements regulating fundamental biological processes, with many poised to impact progenitor cell behaviour.
GSEA detects similarities to other progenitor populations
Gene expression profiles of the embryonic and mammary postnatal cells are largely unique with a limited amount of overlap (Figure 5A, B). Primordial population signatures were used in gene set enrichment analysis . When compared to the luminal postnatal MEC subpopulations, the mammary primordial epithelium displays enrichment for Wnts, Hox genes, phosphatidylinositol, insulin signals, and gene signatures found up-regulated in many hematopoietic progenitor classes. When compared to the basal MECs, the mammary primordial epithelium is enriched for Hox genes, phosphatidylinositol, and insulin signals, but is not enriched for progenitor cell signatures or Wnt signals (Additional file 15). This indicates that the embryonic mammary cells share some genetic features with other progenitor cells, particularly hematopoietic types.
The results presented here give a global picture of the signalling events that may occur as the mammary lineage is first established during mammary primordial organogenesis. Mammary primordial epithelial cells express a distinct entity of genes when compared to those present within the adjacent mammary mesenchymal cells (and vice versa). We have used these gene signatures to define the transcriptomic specificity and signalling cascades that are likely to be mediating reciprocal epithelial-mesenchymal interactions that regulate early mammary tissue organisation, architecture, differentiation and cell fate decisions. Inducing factors such as Nrg3, Eda, Fgf, and Wnt signals have been shown to promote either mammary cell fate and/or epidermal appendage development and key components of these pathways are detected in our analysis [17, 19, 20, 42]. The network maps show how many of the genes expressed by the mammary primordium might converge to elicit complex processes required for morphogenesis such as changing cell adhesion to allow local cell movements required during budding morphogenesis.
Since mammary mesenchyme is an instructive tissue, a strong component of its cell function should be to promote mammary lineage establishment. The mammary primordial epithelial cells profiled here should be receiving signals from the mesenchyme representing key aspects of mammary cell fate acquisition. Comparing gene expression enriched within mammary mesenchyme to that enriched within postnatal mammary stoma identified factors with potential to transmit mammary-inducing signals. Notable candidates with potential mammary-inductive signalling roles include Gas1, which regulates the range and the level of Hedgehog signalling, since down-regulation of Hh signalling is absolutely required for mammary development to proceed [43–45]. Dlk1, an endogenous inhibitor of Notch, could act to repress Notch signals in the mammary primordial epithelium; Notch controls cell fate and tissue homeostasis in postnatal mammary epithelium and could be regulating stem cell function from the time that they arise . Other genes of interest include Arhgap28 and Centd3 since another Rho-GTPase activating protein-encoding gene, Arhgap5, has been shown to regulate epithelial-mesenchymal interactions necessary to sustain mammary bud morphogenesis .
This approach to classifying molecules may be useful for identifying likely mediators of mammary inductive signalling for further study but all diffusible factors expressed by the mammary mesenchyme are potential mammary inducing factors. Signals from purified mammary mesenchyme (isolated using similar methods used in this study) can induce mammary glandular tissue when recombined with simple epithelium across species (mouse to rat) and (rabbit to chicken and duck) so the putative paracrine interactions identified here are likely to occur in other species, including human [34, 48]. A recent study showed that embryonic prostate mesenchyme acts to induce prostate lineage markers in tissue recombinants using several types of non-prostate postnatal epithelium . This notable study supports the contention that mesenchymal and stromal tissues act as lineage enforcers which send signals to epithelial cells to promote and maintain differentiation along a specific lineage. The interconnected epithelial-mesenchymal nodes in our network map predominantly involve signals that involve basal lamina and ECM components and many, such as the integrins, have established roles as cell differentiation and cell adhesion regulators which impact cell shape, changes in cell contact, and cell movements, consistent with the morphogenetic processes that these tissue interactions invoke.
Epithelial Pthlh to mesenchymal Pthr signalling is required for the formation of the mammary mesenchyme and the induction of Tnc expression ; Pthlh represents the most abundant gene expressed by the embryonic mammary epithelium in our dataset. A recent study profiling genes expressed by micro-dissected E15.5 stage Pthlh-/- and wild-type mammary primordia, to study ductal morphogenesis, detected many changes in genes expression by the Pthlh mutant primordia, consistent with Pthlh signalling being a key component of mammary primordial development . However, this analysis did not permit the identification of which of the two tissues the candidates genes were expressed within since the primordia were not separated into their two tissue components. We detected expression of several of the candidate genes that appear to be regulated by Pthlh/Pthr signalling in our core interconnected mammary primordial network module (including INHBB, KRT8, KRT18, KRT19, MATN2, SOSTDC1, TGFBI, THBS1, NRP1, WISP1 and TNC) giving a more precise indication of how this signalling cascade could proceed and connect diverse pathways across the tissues to control reciprocal mesenchymal-epithelial Pthr/Pthlh signals. Our core network reflects signals from an earlier developmental stage (E12.5) at which it is conceivable that Pthlh and Pthr signals are already actively inducing formation of the mammary mesenchyme. The Pthlh/Pthr regulated genes identified by  found in our E12.5 networks are, therefore, likely to reflect some key elements that confer or maintain instructive properties to the mammary mesenchyme. This indicates our datasets and networks represent profound ongoing inductive events and should be useful for identification of novel putative inductive signalling effectors, which can be tested for roles as embryonic mammary development regulators using either transgenic or knockout mouse models, which should soon be available for most genes via ongoing large-scale mouse genome initiatives. As more genes and pathways are determined to regulate embryonic mammary primordial development, these networks can be extended and expanded which will permit assessment of potential genetic hierarchy and pathway convergence and aid experimental design to clarify these issues.
Although the mammary primordium should in theory be predicted to be enriched for stem cells, previous functional analysis suggests that only a very small fraction of the primordial epithelial cells can fulfil the standard definition currently used to assay for mammary stem cell function, that is, the repopulating capacity in the cleared postnatal fat pad . It is possible that this assay is not particularly appropriate for establishing stem cell activity of primordial cells since it selects for more mature stem cells and may exclude less-mature embryonic progenitor cells that are incapable of interacting with the postnatal microenvironment yet fulfil stem cell criterion within their native microenvironment in vivo (that is, they undergo self-renewal and are capable of giving rise to other cells types). Results from gene set enrichment analysis indicate that the primordial cell populations share some transcriptomic features with other progenitor populations from both embryonic and postnatal tissues, particularly hematopoietic progenitors. Recently, s-SHIP promoter expression has been shown to mark activated stem cells in postnatal mammary tissue . It is, therefore, notable that mammary primordial epithelial cells express GFP driven by the s-SHIP promoter , which indicates that the mammary primordial epithelial cells may represent a population of activated primitive mammary progenitor cells. Although by E13.0, the mammary epithelium is determined as mammary, it is highly likely that a large degree of plasticity exists with respect to how committed, (if at all) any of the individual primordial cells are to any particular progenitor type (stem, bipotent, myoepithelial precursor, luminal precursor) within the mammary hierarchy at this stage of development and remains to be explored.
Our results show that substantial transcriptomic differences exist between embryonic mammary cells and postnatal mammary cells, which are most likely due to a unique microenvironment and their immature state. Despite this, the primitive embryonic epithelial and mesenchymal cell populations express a number of genes that have been shown or suggested to regulate postnatal progenitor mammary cell functions. The conserved expression patterns observed across the primordial and postnatal MEC sub-populations suggest that some molecular mechanisms that govern mammary stem cell homeostasis are active as the lineage is first established and continue to regulate this function throughout postnatal development. The early embryonic expression of several known mammary lineage regulators within the primitive mammary epithelium lends support to this idea. In particular, lack of Gata3, one of the most highly expressed genes expressed by the embryonic mammary epithelium in our analysis, leads to defective mammary primordial development at stages prior to E12.5 .
The pathways implicated in cell fate decisions are clearly relevant to transformation as most forms of breast cancer involve deregulation of signalling pathways (Egg, Fgf, Notch, Wnt) that also determine cell identity when cells are initially specified from undifferentiated precursor cells . Embryonic mammary developmental studies will be key to determining how the mammary primordial cells may differentiate and perpetuate amidst a variety of other cell types and signals to first establish an environment or niche for the penultimate mammary progenitor cells. Functional studies of the mammary mesenchyme have demonstrated its profound role in directing and maintaining normal mammary tissue differentiation and architecture; mammary mesenchyme can restore some features of differentiated tissue to mouse mammary tumours when grown together in culture . The identification of molecular effectors that may contribute to the creation of the primitive mammary epithelial and stromal populations provides a basis for selection of novel candidate regulators of mammary lineage establishment, maintenance, and differentiation for further study in both mouse models and cell-based systems. The dataset and analysis presented here represent a framework for studying how cells communicate and act together to produce the organ that defines and sustains all mammals.
- HSPB1 :
HEAT SHOCK PROTEIN 1
median absolute deviation
mammary stem cell
mammary bud epithelium
mammary epithelial cell
quantitative real-time RT-PCR
robust multi-array analysis
Significance Analysis of Microarray
smooth muscle actin
terminal end bud
whole mount in situ hybridisation.
Parmar H, Cunha GR: Epithelial-stromal interactions in the mouse and human mammary gland in vivo. Endocr Relat Cancer. 2004, 11: 437-458. 10.1677/erc.1.00659.
Sakakura T, Nishizuka Y, Dawe CJ: Mesenchyme-dependent morphogenesis and epithelium-specific cytodifferentiation in mouse mammary gland. Science. 1976, 194: 1439-1441. 10.1126/science.827022.
Klinowska TC, Streuli CH: Analyzing cell-ECM interactions in adult mammary gland by transplantation of embryonic mammary tissue from knockout mice. Methods Mol Biol. 2000, 139: 345-358.
Sakakura T, Nishizuka Y, Dawe CJ: Capacity of mammary fat pads of adult C3H/HeMs mice to interact morphogenetically with fetal mammary epithelium. J Natl Cancer Inst. 1979, 63: 733-736.
Kendrick H, Regan JL, Magnay FA, Grigoriadis A, Mitsopoulos C, Zvelebil M, Smalley MJ: Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics. 2008, 9: 591-10.1186/1471-2164-9-591.
Sahlberg C, Mustonen T, Thesleff I: Explant cultures of embryonic epithelium. Analysis of mesenchymal signals. Methods Mol Biol. 2002, 188: 373-382.
Panchal H, Wansbury O, Howard BA: Embryonic mammary anlagen analysis using immunolabelling of whole mounts. Methods Mol Biol. 2010, 585: 261-270. 10.1007/978-1-60761-380-0_18.
Panchal H, Wansbury O, Parry S, Ashworth A, Howard B: Neuregulin3 alters cell fate in the epidermis and mammary gland. BMC Dev Biol. 2007, 7: 105-10.1186/1471-213X-7-105.
Wansbury O, Panchal H, James M, Parry S, Ashworth A, Howard B: Dynamic expression of Erbb pathway members during early mammary gland morphogenesis. J Invest Dermatol. 2008, 128: 1009-1021. 10.1038/sj.jid.5701118.
Ng A, Bursteinas B, Gao Q, Mollison E, Zvelebil M: pSTIING: a 'systems' approach towards integrating signalling pathways, interaction and transcriptional regulatory networks in inflammation and cancer. Nucleic Acids Res. 2006, 34: D527-534. 10.1093/nar/gkj044.
Mouse Genome Informatics website. [http://www.informatics.jax.org]
Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003, 4: P3-10.1186/gb-2003-4-5-p3.
Lim E, Wu D, Pal B, Bouras T, Asselin-Labat ML, Vaillant F, Yagita H, Lindeman GJ, Smyth GK, Visvader JE: Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 2010, 12: R21-10.1186/bcr2560.
Robinson GW: Cooperation of signalling pathways in embryonic mammary gland development. Nat Rev Genet. 2007, 8: 963-972. 10.1038/nrg2227.
Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K, Maeda T, Takano Y, Uchiyama M, Heaney S, Peters H, Tang Z, Maxson R, Maas R: Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet. 2000, 24: 391-395. 10.1038/74231.
Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A: p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999, 398: 708-713. 10.1038/19531.
Mailleux AA, Spencer-Dene B, Dillon C, Ndiaye D, Savona-Baron C, Itoh N, Kato S, Dickson C, Thiery JP, Bellusci S: Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development. 2002, 129: 53-60.
Foley J, Dann P, Hong J, Cosgrove J, Dreyer B, Rimm D, Dunbar M, Philbrick W, Wysolmerski J: Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development. Development. 2001, 128: 513-525.
Andl T, Reddy ST, Gaddapara T, Millar SE: WNT signals are required for the initiation of hair follicle development. Dev Cell. 2002, 2: 643-653. 10.1016/S1534-5807(02)00167-3.
Howard B, Panchal H, McCarthy A, Ashworth A: Identification of the scaramanga gene implicates Neuregulin3 in mammary gland specification. Genes Dev. 2005, 19: 2078-2090. 10.1101/gad.338505.
Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, Lindeman GJ, Visvader JE: Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007, 9: 201-209. 10.1038/ncb1530.
Pispa J, Mustonen T, Mikkola ML, Kangas AT, Koppinen P, Lukinmaa PL, Jernvall J, Thesleff I: Tooth patterning and enamel formation can be manipulated by misexpression of TNF receptor Edar. Dev Dyn. 2004, 231: 432-440. 10.1002/dvdy.20138.
Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999, 398: 714-718. 10.1038/19539.
Cytoscape 2.8.0: An Open Source Platform for Complex Network Analysis and Visualization. [http://www.cytoscape.org]
Sims D, Bursteinas B, Gao Q, Jain E, MacKay A, Mitsopoulos C, Zvelebil M: ROCK: a breast cancer functional genomics resource. Breast Cancer Res Treat. 2010, 124: 567-572. 10.1007/s10549-010-0945-5.
Vogel WF, Aszodi A, Alves F, Pawson T: Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol. 2001, 21: 2906-2917. 10.1128/MCB.21.8.2906-2917.2001.
Robinson GW, Hennighausen L: Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development. 1997, 124: 2701-2708.
McGowan KM, Coulombe PA: Onset of keratin 17 expression coincides with the definition of major epithelial lineages during skin development. J Cell Biol. 1998, 143: 469-486. 10.1083/jcb.143.2.469.
Dunbar ME, Dann PR, Robinson GW, Hennighausen L, Zhang JP, Wysolmerski JJ: Parathyroid hormone-related protein signaling is necessary for sexual dimorphism during embryonic mammary development. Development. 1999, 126: 3485-3493.
Cho KW, Kim JY, Song SJ, Farrell E, Eblaghie MC, Kim HJ, Tickle C, Jung HS: Molecular interactions between Tbx3 and Bmp4 and a model for dorsoventral positioning of mammary gland development. Proc Natl Acad Sci USA. 2006, 103: 16788-16793. 10.1073/pnas.0604645103.
Inaguma Y, Kusakabe M, Mackie EJ, Pearson CA, Chiquet-Ehrismann R, Sakakura T: Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. Dev Biol. 1988, 128: 245-255. 10.1016/0012-1606(88)90288-6.
Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005, 121: 335-348. 10.1016/j.cell.2005.02.034.
Crowley MR, Head KL, Kwiatkowski DJ, Asch HL, Asch BB: The mouse mammary gland requires the actin-binding protein gelsolin for proper ductal morphogenesis. Dev Biol. 2000, 225: 407-423. 10.1006/dbio.2000.9844.
Cunha GR, Young P, Christov K, Guzman R, Nandi S, Talamantes F, Thordarson G: Mammary phenotypic expression induced in epidermal cells by embryonic mammary mesenchyme. Acta Anat (Basel). 1995, 152: 195-204. 10.1159/000147698.
Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 1997, 136: 729-743. 10.1083/jcb.136.3.729.
Santra M, Eichstetter I, Iozzo RV: An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem. 2000, 275: 35153-35161. 10.1074/jbc.M006821200.
Sleeman KE, Kendrick H, Robertson D, Isacke CM, Ashworth A, Smalley MJ: Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol. 2007, 176: 19-26. 10.1083/jcb.200604065.
Kouros-Mehr H, Werb Z: Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev Dyn. 2006, 235: 3404-3412. 10.1002/dvdy.20978.
Oakes SR, Naylor MJ, Asselin-Labat ML, Blazek KD, Gardiner-Garden M, Hilton HN, Kazlauskas M, Pritchard MA, Chodosh LA, Pfeffer PL, Lindeman GJ, Visvader JE, Ormandy CJ: The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev. 2008, 22: 581-586. 10.1101/gad.1614608.
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008, 133: 704-715. 10.1016/j.cell.2008.03.027.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005, 102: 15545-15550. 10.1073/pnas.0506580102.
Mustonen T, Ilmonen M, Pummila M, Kangas AT, Laurikkala J, Jaatinen R, Pispa J, Gaide O, Schneider P, Thesleff I, Mikkola ML: Ectodysplasin A1 promotes placodal cell fate during early morphogenesis of ectodermal appendages. Development. 2004, 131: 4907-4919. 10.1242/dev.01377.
Kang JS, Zhang W, Krauss RS: Hedgehog signaling: cooking with Gas1. Sci STKE. 2007, 2007: pe50-10.1126/stke.4032007pe50.
Gritli-Linde A, Hallberg K, Harfe BD, Reyahi A, Kannius-Janson M, Nilsson J, Cobourne MT, Sharpe PT, McMahon AP, Linde A: Abnormal hair development and apparent follicular transformation to mammary gland in the absence of hedgehog signaling. Dev Cell. 2007, 12: 99-112. 10.1016/j.devcel.2006.12.006.
Hatsell SJ, Cowin P: Gli3-mediated repression of Hedgehog targets is required for normal mammary development. Development. 2006, 133: 3661-3670. 10.1242/dev.02542.
Bouras T, Pal B, Vaillant F, Harburg G, Asselin-Labat ML, Oakes SR, Lindeman GJ, Visvader JE: Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell. 2008, 3: 429-441. 10.1016/j.stem.2008.08.001.
Heckman BM, Chakravarty G, Vargo-Gogola T, Gonzales-Rimbau M, Hadsell DL, Lee AV, Settleman J, Rosen JM: Crosstalk between the p190-B RhoGAP and IGF signaling pathways is required for embryonic mammary bud development. Dev Biol. 2007, 309: 137-149. 10.1016/j.ydbio.2007.07.002.
Propper A, Gomot L: Control of chick epidermis differentiation by rabbit mammary mesenchyme. Experientia. 1973, 29: 1543-1544. 10.1007/BF01943907.
Taylor RA, Wang H, Wilkinson SE, Richards MG, Britt KL, Vaillant F, Lindeman GJ, Visvader JE, Cunha GR, St John J, Risbridger GP: Lineage enforcement by inductive mesenchyme on adult epithelial stem cells across developmental germ layers. Stem Cells. 2009, 27: 3032-3042.
Hens J, Dann P, Hiremath M, Pan TC, Chodosh L, Wysolmerski J: Analysis of gene expression in PTHrP-/- mammary buds supports a role for BMP signaling and MMP2 in the initiation of ductal morphogenesis. Dev Dyn. 2009, 238: 2713-2724. 10.1002/dvdy.22097.
Bai L, Rohrschneider LR: s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue. Genes Dev. 2010, 24: 1882-1892. 10.1101/gad.1932810.
Rohrschneider LR, Custodio JM, Anderson TA, Miller CP, Gu H: The intron 5/6 promoter region of the ship1 gene regulates expression in stem/progenitor cells of the mouse embryo. Dev Biol. 2005, 283: 503-521. 10.1016/j.ydbio.2005.04.032.
Howard B, Ashworth A: Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet. 2006, 2: e112-10.1371/journal.pgen.0020112.
DeCosse JJ, Gossens CL, Kuzma JF, Unsworth BR: Breast cancer: induction of differentiation by embryonic tissue. Science. 1973, 181: 1057-1058. 10.1126/science.181.4104.1057.
Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ: Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009, 15: 907-913. 10.1038/nm.2000.
We thank the Breakthrough Histopathology Facility for their assistance and Dr Stuart Pepper and Yvonne Hey for advice and assistance with the Microarray experiments, Dr Marja Mikkola for advice on tissue separation, Alan Ashworth and Clare Isacke for critical review of the manuscript. This work was funded by Breakthrough Breast Cancer. We acknowledge NHS funding to the NIHR Biomedical Research Centre.
The authors declare that they have no competing interests.
OW isolated RNA, performed in situ hybridisations, IHC, IF and carried out qRT-PCR analysis. AM carried out SAM analysis on the array data and processed the datasets. NK isolated, stained and analysed mammary primordial samples and performed gene set enrichment analyses. KD and CR contributed samples, antibody staining, and manuscript writing and review. HK provided samples and assisted with qRT-PCR analysis. JSR-F and MJS contributed to the design of the study, manuscript writing and review. CM and MZ carried out network analysis on array data. BAH conceived the study, collected primordial samples, analyzed the microarray data and wrote the manuscript. All authors have read and approved the manuscript for publication.
Electronic supplementary material
Additional file 2: The mammary primordial transcriptome. Table A displays relative expression levels of 4,000 Affymetrix probes across three embryonic mouse mammary primordial populations. The spreadsheet gives the relative expression levels for all differentially expressed probes across all three populations. Expression levels are indicated by a relative abundance score for each population. A high positive value indicates expression at a high level, a low negative score indicates very low expression levels. The Affymetrix probe ID, Gene Symbol and q-value (indicating the % false discovery rate) are also indicated. Table B contains genes characteristic of mammary primordial epithelial cells. The table shows all 749 probes in the mammary primordial epithelial population with an abundance score of 1.5 or more when the differentially expressed gene set was sorted by descending abundance scores in the epithelial population. Such genes were considered population-enriched. The number of probes is indicated. Table C contains probes with known expression patterns that were detected as epithelial-specific or epithelial-enriched expression in the arrays. Table D contains probes induced or repressed by tissue separation. Table E contains genes characteristic of mammary primordial mesenchymal cells. The table shows all 642 probes in the mammary primordial mesenchymal population with an abundance score of 1.5 or more when the differentially expressed probe set was sorted by descending abundance scores in the primordial epithelial population. Such genes were considered population-enriched. (XLS 2 MB)
Additional file 3: . (A) A figure summarising select genetic components of the mammary primordial epithelium detected by array analysis. (B) A figure depicting network analysis of the mammary primordial epithelium. (PDF 864 KB)
Additional file 5: . (A) A figure summarising select genetic components of the mammary mesenchyme detected by array analysis. (B) A figure depicting network analysis of the mammary mesenchyme. (PDF 954 KB)
Additional file 7: . This table contains expression patterns of genes enriched in primordial-associated mesenchyme when compared to postnatal mammary stroma in a previously published dataset . Gene expression patterns were overlaid in order to discern enriched secreted factors present only in the mammary mesenchyme that could confer mammary cell phenotype to uninduced surface epithelium. (XLS 399 KB)
Additional file 8: . Table A contains genes expressed by both the mammary mesenchyme and the mature mammary stroma in a previously published dataset . These genes are candidates for promoting mammary differentiation or enforcing mammary lineage commitment. Table B contains genes expressed by human mammary stromal cells in a previously published dataset  which were also found expressed by the mammary mesenchymal cell populations in the current study. (XLS 266 KB)
Additional file 9: . (A) A figure depicting the core interconnected network module. (B) A figure depicting how mesenchymal INHBB is poised to bind to epithelial ACVR1B and ACVR2B. (PDF 917 KB)
Additional file 11: Multiclass SAM analysis of embryonic and postnatal mammary populations. This table displays relative expression levels of 16,382 Affymetrix probes across three embryonic mouse mammary primordial populations and three postnatal mammary epithelial populations. The spreadsheet gives the relative expression levels for all differentially expressed probes across all six populations. Expression levels are indicated by a relative abundance score for each population. A high positive value indicates expression at a high level, a low negative score indicates very low expression levels. The Affymetrix probe ID, Gene Symbol and q-value (indicating the % false discovery rate) are also indicated. (XLS 9 MB)
Additional file 12: . This table contains genes common to primordial cells and basal cell dataset and luminal cell datasets from . The table lists those basal genes, LumER- genes, and LumER+ genes found in a previously published dataset  which were also found in the primordial epithelial or mesenchymal populations in the current study. A mouse stromal signature from  was used to determine which genes were also found in the primordial epithelial or mesenchymal populations. Genes expressed by embryonic mammary primordial cells and the cells contained within the terminal end bud and ductal microenvironments from  are also listed. (XLS 82 KB)
Additional file 13: . (A) Venn diagrams showing comparison of genes expressed by embryonic mammary primordial cells to those expressed by the cells contained within the terminal end bud and ductal microenvironments from . (B) A heatmap showing the expression of a variety of key developmental, lineage, and progenitor markers in embryonic and postnatal mammary cell populations. (C) Venn diagram showing comparison of genes expressed by embryonic mammary primordial cells to those expressed by the conserved mouse/human MEC subpopulations and human fibroblasts from [13, 55]. (PDF 1 MB)
Additional file 14: . This table contains genes common to primordial cells and conserved mouse/human mammary stem/myoepithelial cells, luminal progenitors or mature luminal cell dataset from . The table lists those conserved mouse/human genes expressed by mammary stem cell (MaSC) or myoepithelial cells, luminal progenitors (lum prog), and mature luminal (lum mature) cells found in a previously published dataset  which were also found expressed by the primordial epithelial (MBE) or mesenchymal (MM) populations in the current study. The human stromal signature defined in  was used to determine which genes were also found in the primordial epithelial or mesenchymal populations. (XLS 86 KB)
Additional file 15: . This file contains the gene sets (with a nominal P-value of < 0.05 in order of significance) enriched in primordial cells and postnatal cells when the two data sets were compared. Gene sets with similarity to progenitor populations are in italics and underlined. Gene sets with a FDR q value of < 0.50 are in bold. (XLS 64 KB)
About this article
Cite this article
Wansbury, O., Mackay, A., Kogata, N. et al. Transcriptome analysis of embryonic mammary cells reveals insights into mammary lineage establishment. Breast Cancer Res 13, R79 (2011). https://doi.org/10.1186/bcr2928
- Mammary Epithelium
- Mammary Stem Cell
- Mammary Lineage
- Primordial Cell
- Mammary Mesenchyme